Showing results (141-150 of 253) with videos related to
Sort By:
Pageof 26
Platelets|October 27, 2009
Nephropathy in type 1 diabetes is associated with increased circulating activated platelets and platelet hyperreactivityInge Tarnow, Alan D Michelson, Marc R Barnard, et al.Journal of the American Society of Nephrology : JASN|September 19, 2009
Cost-effectiveness of aliskiren in type 2 diabetes, hypertension, and albuminuriaThomas E Delea, Oleg Sofrygin, James L Palmer, et al.Diabetes Care|November 2, 2011
Vitamin D levels and asymptomatic coronary artery disease in type 2 diabetic patients with elevated urinary albumin excretion rateChristel Joergensen, Henrik Reinhard, Anne Schmedes, et al.Diabetes Care|March 18, 2008
Plasma connective tissue growth factor is an independent predictor of end-stage renal disease and mortality in type 1 diabetic nephropathyTri Q Nguyen, Lise Tarnow, Anders Jorsal, et al.Diabetic Medicine : a Journal of the British Diabetic Association|November 12, 2020
Visit-to-visit variability of clinical risk markers in relation to long-term complications in type 1 diabetesViktor Rotbain Curovic, Simone Theilade, Signe Abitz Winther, et al.Cardiovascular Diabetology|July 13, 2017
Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuriaEmilie H Zobel, Bernt Johan von Scholten, Henrik Reinhard, et al.Lancet (London, England)|November 9, 2010
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trialDick de Zeeuw, Rajiv Agarwal, Michael Amdahl, et al.Diabetes Care|July 10, 2009
Renal effects of aliskiren compared with and in combination with irbesartan in patients with type 2 diabetes, hypertension, and albuminuriaFrederik Persson, Peter Rossing, Henrik Reinhard, et al.BMC Endocrine Disorders|June 26, 2012
A prospective randomised cross-over study of the effect of insulin analogues and human insulin on the frequency of severe hypoglycaemia in patients with type 1 diabetes and recurrent hypoglycaemia (the HypoAna trial): study rationale and designPeter Lommer Kristensen, Ulrik Pedersen-Bjergaard, Henning Beck-Nielsen, et al.Kidney International|March 23, 2012
Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockersHiddo J Lambers Heerspink, Frank A Holtkamp, Hans-Henrik Parving, et al.Pageof 26